S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
CADL · Candel Therapeutics, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Candel Therapeutics Inc (CADL)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$8.35
-0.29
(-3.36%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$8.35
$8.35
$8.78
52-WEEK RANGE
$8.35
$4.35
$14.00
What's happening
- CADL is down 3.36% today, trading at $8.35. — Live quote
- Volume today (76,250) is well below its 3-month average of 1,390,280. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.52 actual vs. $-0.24 estimated (-115.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 9
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (15 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CADL
+52.92%
vs S&P 500
+40.14%
1-YEAR RETURN
CADL
+55.96%
vs S&P 500
+41.40%
6-MONTH RETURN
CADL
+67.44%
3-MONTH RETURN
CADL
-15.46%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.52
Est. $-0.24
MISS -115.4%
2026-04-26 (Q1 2026)
$-0.14
Est. $-0.32
BEAT +56.7%
2026-01-26 (Q4 2025)
$-0.54
Est. $-0.25
MISS -115.3%
2025-10-26 (Q3 2025)
$-0.21
Est. $-0.19
MISS -11.2%
Valuation Measures & Ratios
Enterprise Value4$486.7M
Forward P/E5—
PEG Ratio6-0.06
Price / Sales (TTM1)5165.00
Price / Book75.98
EV4 / Revenue3925.21
EV4 / EBITDA—
Profit Margin-15156.45%
Operating Margin-28000.81%
Return on Equity (ROE8)-89.38%
Return on Assets (ROA9)-56.31%
Avg Volume (3M)1,390,280
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $771.4M | $310.8M | $273.7M | $268.8M | $320.7M |
| P/E | -12.08 | -17.71 | -14.16 | -8.87 | -9.51 |
| Price/Book | 6.12 | 2.25 | 3.42 | 2.98 | 4.29 |
| ROE | -50.61% | -12.71% | -24.13% | -33.59% | -45.16% |
| ROA | -30.67% | -8.69% | -20.65% | -28.59% | -35.17% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short13,000,504
Change from Prior Settlement+5.31%
% of Float—
Days to Cover (Short Ratio)11.15
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +56.0%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -15156.5%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-02; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CADL
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | -$26.7M | -$16.3M | -$13.2M | -$11.2M | -$8.1M | -$8.8M | -$8.6M | -$7.9M |
| Net income | -$38.9M | -$8.9M | -$11.3M | -$4.8M | $7.4M | -$10.6M | -$22.2M | -$8.2M |
| EPS (diluted) | $-0.52 | $-0.14 | $-0.21 | $-0.09 | $0.13 | $-0.33 | $-0.74 | $-0.28 |
| EPS (basic) | $-0.52 | $-0.14 | $-0.21 | $-0.09 | $0.15 | $-0.33 | $-0.74 | $-0.28 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $208.1M | $201.9M | $125.2M | $93.6M | $106.0M | $95.9M | $106.9M | $21.5M |
| Total liabilities | $82.0M | $63.9M | $73.3M | $13.5M | $15.8M | $21.2M | $40.5M | $36.8M |
| Stockholders' equity | $126.1M | $138.0M | $51.9M | $80.1M | $90.2M | $74.7M | $66.3M | -$15.3M |
| Total current assets | $204.2M | $197.8M | $121.4M | $90.1M | $103.6M | $93.1M | $103.8M | $18.1M |
| Total current liabilities | $12.7M | $7.1M | $9.0M | $10.9M | $14.7M | $20.1M | $37.5M | $15.3M |
| Cash & equivalents | $201.6M | $194.8M | $119.7M | $87.0M | $100.7M | $92.2M | $102.7M | $16.6M |
| Property, plant & equipment | $2.0M | $2.1M | $1.6M | $1.4M | $1.7M | $2.0M | $2.2M | $2.5M |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Accounts payable | $5.2M | $3.0M | $1.1M | $1.1M | $2.0M | $760.0K | $237.0K | $296.0K |
| Accrued liabilities | $7.0M | $3.5M | $7.3M | $5.1M | $4.3M | $2.7M | $5.1M | $4.6M |
| Short-term debt | — | — | $0 | $4.2M | $6.7M | $9.2M | $9.9M | $9.9M |
| Other current liabilities | $89.0K | $89.0K | $89.0K | — | — | — | $0 | — |
| Long-term debt | — | — | — | — | — | — | $1.7M | $4.2M |
| Common stock & paid-in capital | $761.0K | $733.0K | $550.0K | $550.0K | $549.0K | $493.0K | $469.0K | $322.0K |
| Retained earnings | -$278.2M | -$239.2M | -$230.4M | -$200.9M | -$189.6M | -$184.8M | -$192.2M | -$178.1M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$17.2M | -$18.0M | -$10.6M | -$10.2M | -$8.9M | -$8.6M | -$5.8M | -$6.6M |
| Investing cash flow | -$69.0K | -$675.0K | -$409.0K | -$117.0K | -$31.0K | -$3.0K | -$3.0K | $0 |
| Financing cash flow | $24.0M | $93.8M | $43.9M | -$3.4M | $17.4M | -$1.9M | $91.9M | $1.7M |
| Free cash flow | -$17.3M | -$18.7M | -$11.0M | -$10.4M | -$8.9M | -$8.6M | -$5.8M | -$6.6M |
| Capital expenditures | $69.0K | $675.0K | $409.0K | $144.0K | $31.0K | $3.0K | $3.0K | $0 |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $2.9M | $1.5M | $1.3M | $1.2M | $1.1M | $314.0K | $1.2M | $1.2M |
| Change in accounts payable | $2.4M | $1.7M | $33.0K | -$744.0K | $1.0M | $507.0K | -$56.0K | -$140.0K |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $125.0K | $125.0K |
| Operating income | -$48.3M | -$33.4M | -$38.4M | -$34.7M | -$25.7M |
| Net income | -$38.2M | -$55.2M | -$37.9M | -$18.8M | -$36.1M |
| EPS (diluted) | $-0.72 | $-1.74 | $-1.31 | $-0.65 | $-1.91 |
| EPS (basic) | $-0.72 | $-1.74 | $-1.31 | $-0.65 | $-1.91 |
| Operating margin | — | — | — | -$27.8K | -$20.6K |
| Net margin | — | — | — | -$15.0K | -$28.9K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $125.2M | $106.9M | $41.2M | $77.7M | $89.2M |
| Total liabilities | $73.3M | $40.5M | $28.5M | $30.0M | $25.1M |
| Stockholders' equity | $51.9M | $66.3M | $12.7M | $47.7M | $64.1M |
| Total current assets | $121.4M | $103.8M | $36.8M | $71.9M | $84.9M |
| Total current liabilities | $9.0M | $37.5M | $14.2M | $5.6M | $5.4M |
| Cash & equivalents | $119.7M | $102.7M | $35.4M | $70.1M | $82.6M |
| Property, plant & equipment | $1.6M | $2.2M | $3.2M | $4.4M | $3.8M |
| Other non-current assets | — | — | — | — | $424.0K |
| Accounts payable | $1.1M | $237.0K | $422.0K | $380.0K | $1.6M |
| Accrued liabilities | $7.3M | $5.1M | $4.4M | $4.7M | $3.4M |
| Short-term debt | $0 | $9.9M | $8.9M | — | — |
| Other current liabilities | $89.0K | $0 | — | $48.0K | $334.0K |
| Long-term debt | — | $1.7M | $11.6M | — | — |
| Common stock & paid-in capital | $550.0K | $469.0K | $290.0K | $290.0K | $286.0K |
| Retained earnings | -$230.4M | -$192.2M | -$137.0M | -$99.1M | -$80.3M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$38.3M | -$27.0M | -$34.2M | -$31.4M | -$22.2M |
| Investing cash flow | -$560.0K | -$16.0K | -$280.0K | -$1.3M | -$1.8M |
| Financing cash flow | $56.1M | $94.3M | -$121.0K | $20.0M | $71.8M |
| Free cash flow | -$38.9M | -$27.0M | -$34.7M | -$32.7M | -$24.1M |
| Capital expenditures | $587.0K | $16.0K | $457.0K | $1.3M | $1.8M |
| Depreciation & amortization | — | — | — | $778.0K | $232.0K |
| Share-based compensation | $3.8M | $5.3M | $3.1M | $2.3M | $3.0M |
| Change in accounts payable | $802.0K | -$185.0K | $45.0K | -$1.2M | $669.0K |
| Purchases of investments | — | — | — | — | — |
| Tax withholding on stock comp | — | — | $121.0K | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CADL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers62.4%
Shares Outstanding76,118,276
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| FMR LLC | 10,990,535 | $113.2M | 14.44% | +0.0% | 2026-08-13 |
| RTW INVESTMENTS, LP | 6,422,018 | $66.1M | 8.44% | +0.0% | 2026-08-14 |
| BlackRock, Inc. | 4,969,040 | $51.2M | 6.53% | +59.8% | 2026-08-07 |
| State Street Corp | 3,549,823 | $36.6M | 4.66% | +333.7% | 2026-08-07 |
| ACORN CAPITAL ADVISORS, LLC | 3,497,948 | $36.0M | 4.60% | +0.0% | 2026-08-14 |
| Portolan Capital Management, LLC | 3,490,398 | $36.0M | 4.59% | +20.6% | 2026-08-14 |
| Saturn V Capital Management LP | 3,303,686 | $34.0M | 4.34% | +14.1% | 2026-08-14 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,694,040 | $27.7M | 3.54% | +9.4% | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,571,021 | $16.2M | 2.06% | +51.7% | 2026-08-12 |
| MILLENNIUM MANAGEMENT LLC | 1,093,905 | $11.3M | 1.44% | +3.2% | 2026-08-14 |
| Halter Ferguson Financial Inc. | 772,461 | $8.0M | 1.01% | -14.6% | 2026-08-03 |
| Northern Trust Corp | 492,465 | $5.1M | 0.65% | +52.4% | 2026-08-12 |
| KENNEDY CAPITAL MANAGEMENT LLC | 488,291 | $5.0M | 0.64% | +427.2% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 437,150 | $4.5M | 0.57% | +63.0% | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 412,109 | $4.2M | 0.54% | +46.9% | 2026-06-30 |
| Sands Capital Alternatives, LLC | 405,837 | $4.2M | 0.53% | +0.0% | 2026-08-13 |
| Goldman Sachs Group Inc | 305,216 | $3.1M | 0.40% | +34.1% | 2026-08-14 |
| MARSHALL WACE, LLP | 300,641 | $3.1M | 0.39% | +0.0% | 2026-08-13 |
| Arete Wealth Advisors, LLC | 289,663 | $3.0M | 0.38% | +0.0% | 2026-08-11 |
| Bank Of America Corp /De/ | 278,944 | $2.9M | 0.37% | +488.5% | 2026-08-14 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 227,939 | $2.3M | 0.30% | +101.8% | 2026-08-14 |
| WELLINGTON MANAGEMENT GROUP LLP | 205,745 | $2.1M | 0.27% | +0.0% | 2026-08-14 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 199,454 | $2.1M | 0.26% | +78.5% | 2026-08-14 |
| Tanager Wealth Management LLP | 198,175 | $2.0M | 0.26% | +0.0% | 2026-07-23 |
| Bank of New York Mellon Corp | 191,701 | $2.0M | 0.25% | +40.7% | 2026-08-06 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Insider activity is not available for this symbol right now.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:57 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-10 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-10 | 8-K | 2026-09-06 | View on SEC.gov → |
| 2026-09-09 | 8-K | 2026-09-09 | View on SEC.gov → |
| 2026-08-19 | 4 | 2026-08-17 | View on SEC.gov → |
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-13 | 8-K | 2026-08-13 | View on SEC.gov → |
| 2026-07-08 | 4 | 2026-07-06 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-29 | View on SEC.gov → |
Recent news
Headlines about CADL (Candel Therapeutics, Inc.). Links open the publisher — we don’t host full articles.
-
CADL Jan 2027 7.000 call (CADL270115C00007000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-18 -
(CADL) Movement Within Algorithmic Entry Frameworks
Stock Traders Daily · 2026-10-17 -
CADL Apr 2027 16.000 put (CADL270416P00016000) Interactive Stock Chart - Yahoo Finance
Yahoo! Finance Canada · 2026-10-15 -
CADL Apr 2027 16.000 put (CADL270416P00016000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-15 -
CADL Apr 2027 8.000 call (CADL270416C00008000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-15 -
CADL Apr 2027 18.000 call (CADL270416C00018000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-15 -
CADL Apr 2027 9.000 call (CADL270416C00009000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-15 -
CADL Apr 2027 14.000 put (CADL270416P00014000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-15
No headlines in this category right now — try “All”.